Top Ten Myths About Psychedelics: Separating Fact from Fiction

- Steve Elfrink

‍

Psychedelics are gaining attention as powerful tools for mental health and self-discovery, yet misconceptions abound. These myths, often rooted in decades-old misinformation, can prevent people from understanding the potential benefits and risks of psychedelics. Below, we explore the top ten myths about psychedelics, providing a detailed, evidence-based perspective to help newcomers better understand these substances.

‍

Myth 1: Psychedelics Are Just "Party Drugs"

Fact: Psychedelics like psilocybin, LSD, and MDMA are not inherently recreational substances. While some people use them casually, their origins and therapeutic applications are far more profound. Indigenous cultures have used psilocybin mushrooms, ayahuasca, and peyote for centuries in spiritual and healing ceremonies. These substances are sacred tools for connecting with the divine and promoting communal healing.

‍

Modern clinical research, such as studies conducted at Johns Hopkins University and Imperial College London, highlights the therapeutic potential of psychedelics. For example, a 2016 Johns Hopkins study found that psilocybin-assisted therapy significantly reduced depression and anxiety in cancer patients, with effects lasting up to six months. These outcomes are far removed from the hedonistic stereotypes associated with "party drugs."

‍

Myth 2: Psychedelics Cause Brain Damage

Fact: The notion that psychedelics cause brain damage stems from early propaganda, such as the infamous "brain on drugs" campaigns. Current neuroscience tells a different story. Studies using functional MRI and EEG have shown that psychedelics temporarily reduce activity in the brain's default mode network (DMN), which is associated with self-referential thinking and rumination. This suppression can promote novel connections between different brain regions.

‍

Research by Dr. Robin Carhart-Harris at Imperial College London has demonstrated that psilocybin fosters neuroplasticity, enabling the brain to rewire itself. A 2021 study published in Neuron found that psychedelics like DMT (found in ayahuasca) increase the growth of dendritic spines, which are small protrusions on neurons involved in learning and memory.

‍

Myth 3: Psychedelics Will Make You Go "Crazy"

Fact: The idea that psychedelics cause insanity has been debunked by decades of research. While intense psychedelic experiences can temporarily induce states of confusion or emotional distress, they rarely lead to long-term psychosis in individuals without pre-existing mental health vulnerabilities. The Journal of Psychopharmacology published a study in 2013 analyzing over 130,000 respondents from the National Survey on Drug Use and Health, finding no link between psychedelic use and increased rates of mental health disorders.

‍

However, it's important to note that psychedelics can exacerbate latent mental health issues in those predisposed to schizophrenia or psychosis. Screening for these conditions is a vital part of therapeutic protocols to minimize risks. Additionally, some individuals may experience adverse reactions such as panic attacks, paranoia, or disorientation during a psychedelic experience. Therefore, it's crucial to approach these substances with caution and under the guidance of trained professionals.

‍

Myth 4: Psychedelics Are Addictive

Fact: Psychedelics are among the least addictive substances. They do not affect the brain’s dopamine reward pathways in the way that drugs like cocaine, methamphetamine, or opioids do. Substances like psilocybin and LSD often result in a rapid tolerance build-up, meaning repeated use within a short period yields diminishing effects—discouraging habitual use.

‍

Moreover, psychedelics show promise in treating addiction. For instance, a 2014 study published in the Journal of Psychopharmacology found that psilocybin-assisted therapy helped people quit smoking, with an abstinence rate of 80% after six months. Other studies suggest that psychedelics can reduce cravings for alcohol and opioids, offering hope for addiction treatment.

‍

Myth 5: You’ll Lose Control of Yourself on Psychedelics

Fact: Psychedelics alter perceptions, but they do not make users lose control of their actions or become utterly unaware of their surroundings. Most people remain conscious and able to interact with others during a psychedelic experience. However, they may experience intense emotions, sensory distortions, or visions.

‍

A critical factor in shaping a psychedelic experience is what's known as 'set and setting,' a concept popularized by psychedelic researcher Dr. Timothy Leary. 'Set' refers to the mindset of the individual taking the substance, including their expectations, mood, and mental state. 'Setting' refers to the physical and social environment in which the experience takes place.

‍

Research has shown that a calm mindset and a supportive environment significantly reduce the likelihood of panic or disorientation during a psychedelic experience. Clinical protocols prioritize safety, such as having trained guides or therapists present to assist users in navigating challenging experiences.

‍

‍

Myth 6: Psychedelics Are "Quick Fixes" for Mental Health Issues

Fact: Psychedelics can catalyze profound psychological breakthroughs, but their effects are not automatic or guaranteed. Studies at NYU and Johns Hopkins have shown that psilocybin therapy can result in lasting reductions in depression and anxiety, but these outcomes depend on proper integration. This involves reflecting on the experience, discussing it with therapists, and applying insights to daily life, a crucial step that users should be aware of and prepared for.

‍

For instance, a 2020 JAMA Psychiatry study found that two doses of psilocybin, combined with psychotherapy, produced rapid and sustained antidepressant effects. However, participants were guided through weeks of preparatory and follow-up therapy, emphasizing that psychedelics are tools within a more extensive healing process—not standalone cures.

‍

Myth 7: All Psychedelics Are the Same

Fact: Psychedelics vary widely in their chemical structures, effects, and therapeutic uses. Psilocybin mushrooms primarily induce introspection and spiritual experiences, while LSD often produces heightened sensory awareness and prolonged trips lasting up to 12 hours. Ayahuasca, a traditional Amazonian brew, is known for its purgative and vision-inducing effects, often used in ceremonial settings.

‍

MDMA, though not a classic psychedelic, enhances emotional openness and is particularly effective in treating PTSD. A 2021 phase 3 clinical trial published in Nature Medicine demonstrated that MDMA-assisted therapy resulted in significant reductions in PTSD symptoms, with 67% of participants no longer qualifying for a PTSD diagnosis after treatment.

‍

Myth 8: Psychedelics Are Illegal Everywhere

Fact: The legal status of psychedelics is evolving. In 2020, Oregon became the first state to legalize psilocybin therapy, and Colorado followed in 2022. Several U.S. cities, including Denver, Oakland, and Santa Cruz, have decriminalized psychedelics. Internationally, countries like Brazil and Peru allow the use of ayahuasca in religious contexts. However, it's important to note that the legal status of psychedelics varies widely across different jurisdictions, and their use and possession may still be illegal in many places.

‍

MDMA is on the verge of FDA approval for therapeutic use, potentially by 2026, thanks to extensive research conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS). These shifts indicate growing recognition of the therapeutic value of psychedelics.

‍

Myth 9: Psychedelic Experiences Are Always Fun and Easy

Fact: Psychedelic experiences can be intense and challenging. Many people report facing unresolved emotions or reliving traumatic memories. This phenomenon, sometimes called a 'bad trip,' is not inherently harmful when handled in a safe environment. Research suggests that confronting these problematic aspects of the psyche can lead to transformative healing, offering hope for those struggling with mental health issues.

‍

A 2016 study published in Psychopharmacology found that 84% of participants who reported challenging experiences with psilocybin later considered the experience beneficial, describing increased psychological insight and personal growth.

‍

Myth 10: Psychedelics Have No Lasting Benefits

Fact: Evidence suggests that psychedelics can produce enduring positive changes in mental health and personality. A landmark study by Johns Hopkins in 2011 found that a single psilocybin session increased openness, a personality trait associated with creativity and curiosity. These changes were still measurable over a year later.

‍

For mental health, psychedelics have shown remarkable results in clinical settings. For example, a 2020 study in Nature Medicine found that MDMA-assisted therapy had sustained benefits for PTSD patients, even 12 months after treatment. Similarly, psilocybin therapy has been shown to reduce symptoms of depression and anxiety for months after just a few sessions.

‍

Conclusion: The Importance of Education and Respect

Psychedelics are powerful substances with the potential to heal, but they must be approached with respect, education, and proper guidance. Dispelling myths is essential to fostering informed conversations and encouraging safe practices. As research continues to uncover the therapeutic potential of psychedelics, their role in modern medicine and personal growth becomes clearer. By understanding the facts, newcomers can approach psychedelics with the knowledge needed for safe and meaningful exploration.